Navigation Links
Takeda's Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
Date:5/22/2008

SAN FRANCISCO, May 22 /PRNewswire/ -- Takeda San Francisco Inc. announced today the appointment of Mary Haak-Frendscho, Ph.D., as president and chief scientific officer. Dr. Haak-Frendscho will be responsible for leading all activities at Takeda San Francisco including overall research and preclinical development, process development studies and operations for antibody therapeutics.

Takeda San Francisco is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited of Osaka, Japan ("Takeda").

"Dr. Haak-Frendscho's strong leadership skills and biotechnology experience will greatly contribute to the success of Takeda San Francisco," said Shigenori Ohkawa, Ph.D., general manager, pharmaceutical research division, Takeda. "Takeda San Francisco will play an increasingly critical role in the expansion of Takeda's R&D capabilities as we look to promote the development of antibody therapeutics, and I am confident that Dr. Haak-Frendscho will help us realize our goals in the antibody field."

With more than 17 years of pharmaceutical and biotechnology experience, Dr. Haak-Frendscho has held positions at Genentech, Abgenix and most recently, at XOMA, where she served as chief science officer and vice president, preclinical research and development.

"I feel honored to join Takeda San Francisco," said Dr. Haak-Frendscho. "My background in biotechnology coupled with Takeda San Francisco's impressive existing antibody research is a natural fit, and will help realize Takeda's plan of creating new drugs through in-house R&D activities. I look forward to working with Takeda San Francisco's talented team to develop products that will improve the lives of patients."

Dr. Haak-Frendscho conducted post-doctorate work at the department of immunology, Genentech Inc., in preclinical in vitro and in vivo research and development of a humanized mAb therapeutic product candidate MaE11/MaE25 (Xolair(R)). She holds a doctorate in immunology from th
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product
2. ARIUS presents new findings for anti-cancer antibody programs at AACR
3. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
4. Antibody Engineering Company F-Star Buys Back Royalty Obligations
5. Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
6. Antibody Engineering Company f-Star Opens Second Research Site in Cambridge, UK
7. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
8. Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance
9. ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops
10. Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility
11. Vaccinex Antibody Licensed to GlaxoSmithKline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Dec. 2 Reportlinker.com announce...n its catalogue: ,, Carbondioxide Incubators -...portlinker.com/p0164368/Carbondioxide-Incubators--...rs are the most critical equipment used in microbi...cations for providing a controlled environment to ...
(Date:12/2/2009)...f., Dec. 2 Peregrine Pha... completion of patient enrollment in a dose confir...ents with relapsed glioblastoma multiforme (GBM), ...argeted monoclonal antibody linked to a radioisoto...r GBM. Cotara specifically targets cells at the c...
(Date:12/2/2009)..., Mass., Dec. 2 TechConnect World,...ogy development and product integration in cleante...mber 11th deadline for technology abstracts and bu...TechConnect World, in association with the Nano Sc...an Technology and Sustainable Industries Organizat...
(Date:12/2/2009)... China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharma... SCR ), a leading pharmaceutical company,special...ting of branded,generic and proprietary pharmaceut...ugs have been included in China,s National Drug Re...na,s Ministry of Human Resources and Social,Securi...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
..., , , , Kathryn L. Dudeck and Wend... Department of Marine Sciences, , , ... , This application describes the u...improving PCR efficiency when studying functional ...t was possible to amplify a 675 bp region of the a...
... , , , Multiporator , , , ... Transfection Protocol , Protoc..., , , , , , , , ... T98G, human glioblastoma, , ,...d pEGFP-N1 (in bidistilled H 2 O), , ...
... , , , Multiporator / Electroporato... , , Transformation Proto...02 , , , , , , ,... Microorganism , Staphylococcus aureu..., Bacteria, gram positive, , ...
Other Biology Technology:Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using , Eppendorf MasterTaq 2Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using , Eppendorf MasterTaq 3T98G 2Staphylococcus aureus 2
(Date:12/3/2009)...asured CO2 levels for the past three years in the ...abited rural area near Valladolid. The results, wh...insula, show that the levels rose "significantly" ...icists and meteorologists have been trying to find...ese have evolved in the troposphere over various u...
(Date:12/3/2009)...ts from the U.S. Department of Energy,s (DOE) Broo...d the Indian Institute of Science has made a major...netic information in DNA that is necessary to carr..., published in the December 1, 2009 edition of Na...t many proteins responsible for interacting at spe...
(Date:12/2/2009)...sed to secondhand cigarette smoke have an increase...n if they never smoked. , Results of this study... & Prevention , a journal of the American Associat...cco focus in the December issue. , This year al... with lung cancer; more than 159,000 will die from...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Grooving down the helix 2Grooving down the helix 3Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Research proves tai chi benefits for arthritis 49032 1Research proves tai chi benefits for arthritis 49032 2US Farms Inc Launches Aloe Vera Juice Web Site for Hispanic Market 49029 1US Farms Inc Launches Aloe Vera Juice Web Site for Hispanic Market 49029 2US Farms Inc Launches Aloe Vera Juice Web Site for Hispanic Market 49029 3Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 1Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 2Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 3Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 4Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 5
...ased an automated literature search tool for the m...tool is available as a free plug-in to Cytoscape 2...ables researchers to form a visual map of complex ...g of molecular pathways and the biological causes ...utomatically searches for and extracts information...
...e than 1 million deaths worldwide every year and s...fy the molecular events that result in the initiat...stablished that interfering with the function of o...as a profound effect on the cells lining the inner...d causes them to lose control over their prolifera...
...hicago have identified a method of assessing the m...ty of cellular DNA to enzyme digestion. The articl...vity to Alu I restriction enzyme decreases with ma...rix and cytoskeleton," appears in the April 2005 i...ccompanied by a commentary. , Using an enzyme (Alu...
Other Biology News:Agilent Technologies releases automated literature search tool for biology researchers 2Agilent Technologies releases automated literature search tool for biology researchers 3Research Using Mouse Models Reveals A Novel Key Player In The Initiation Of Colon Cancer 2Study of genomic DNA leads to new advances in cancer diagnostics 2
Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Mouse Anti-Human PPOX Monoclonal Antibody, Unconjugated, Clone 2F10 from ABR-Affinity BioReagents
Rabbit Anti-Raf1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human KRIT1 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: